Come up with a name for your new list and we'll add to it:
FreeStride Therapeutics raised a round of funding on September 23, 2009. Investors include
Michigan Pre-Seed Capital Fund.
FreeStride Therapeutics is developing and marketing a veterinary drug to address bone and inflammation problems, resulting in lameness and/or inability to perform, in horses and dogs primarily.…